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High- to Low-Dose Extrapolation: Critical
Determinants Involved in the Dose
Response of Carcinogenic Substances
by James A. Swenberg,* Frank C. Richardson,* Joyce A.
Boucheron,* Frank H. Deal,* Steven A. Belinsky,t Michel
Charbonneau,* and Brian G. Short*
Recent investigations on mechanisms of carcinogenesis have demonstrated important quantitative re-
lationships between the induction of neoplasia, the molecular dose of promutagenic DNA adducts and
their efficiency for causing base-pair mismatch, and the extent ofcell proliferation in target organ. These
factors are involved in the multistage process of carcinogenesis, including initiation, promotion, and
progression. The molecular dose ofDNA adducts can exhibit supralinear, linear, orsublinearrelationships
to external dose due to differences in absorption, biotransformation, and DNA repair at high versus low
doses. In contrast, increased cell proliferation is a common phenomena that is associated with exposures
to relatively high doses oftoxic chemicals. As such, it enhances the carcinogenic response at high doses,
but has little effect at low doses. Since data on cell proliferation can be obtained for any exposure scenario
and molecular dosimetry studies are beginning to emerge on selected chemical carcinogens, methods are
needed so that these critical factors can be utilized in extrapolation from high to low doses and across
species. The use of such information may provide a scientific basis for quantitative risk assesesment.
Introduction
Tumorincidence datafrom chronicbioassays on many
important industrial and environmental chemicals are
increasingly being factored into quantitative assess-
ments of potential cancer risk. These estimates of risk
are usually forhuman exposures that are orders ofmag-
nitude lower than those used in the animal studies. For
such estimates to be accurate, one must first identify
which factors are critical determinants in the dose-re-
sponse relationship for carcinogenesis, and then appro-
priately weigh those factors that change between high
and low exposure.
Recently, considerable attention has focused on the
potential of using "molecular dose" as one such factor
(1-3). The molecular dose isthe amount ofan agent that
reaches a critical target site, usually a macromolecule
such as DNA or hemoglobin. The actual entity that is
quantitated (i.e., DNA adduct) is the molecular dosi-
meter, and the process ofmeasuring the molecular dose
is termed "molecular dosimetry." Since many factors
such as absorption, distribution, and biotransformation
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represent saturable processes, it is probable that the
molecular dose will bear a closer relationship to biolog-
ical effects than would external exposure. If metabolic
activation becomes saturated, as is the case for vinyl
chloride (4) and NNK (5-7), then exposures above the
saturation point would result in molecular doses lower
than predicted. On the other hand, ifdetoxification be-
comes saturated at high exposure, the molecular dose
would be higher than would be predicted from the low
exposure data. Thus, bioactivation and detoxification
are critical determinants in extrapolation from high to
low doses.
Since cancer is believed to involve heritable changes
and DNA is the material that carries heritable infor-
mation, DNA adducts have been closely studied as po-
tential molecular dosimeters for genotoxic carcinogens.
Unfortunately, many carcinogens react at more than
one site on DNA, producing several types of DNA ad-
ducts. Therefore, it becomes important to consider all
available biological data, including rate of formation,
repair, and mutagenic efficiency, when choosing the
most appropriate DNA adducts to be used as molecular
dosimeters. For example, alkylating agents modify
DNA at the ring nitrogens and exocyclic nitrogens and
oxygens of pyrimidine and purine bases. Adducts re-
sulting from alkylation at ring nitrogens (i.e., N-7-
deoxyguanosine and N-3-deoxyadenosine) show littleSWENBERG ETAL.
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FIGURE 1. Quantitative factors that are involved in the mutational
events of initiation include the number and efficiency of DNA
adducts for causing mutations when cell replication occurs prior
to DNA repair. Rapidly proliferating cells have less time between
successive cell divisions for DNA repair and are therefore more
likely to be initiated.
correlation with tumor formation (8). In contrast, a
large body ofevidence has demonstrated that alkylation
of the exocyclic oxygens, especially 06-alkyldeoxygu-
anosine (06-alkyldG) (8-10) and 04-alkyldeoxythymi-
dine (04-alkyldT) (11,12), does correlate with tumori-
genesis, mutagenesis, and the ability to mispair during
replication (13,14). Thus, in the case of alkylating
agents, it may be necessary to monitor more than one
DNA adduct, since several adducts could be contrib-
uting to the carcinogenic process. Simple alkylating
agents may represent the most complex carcinogens
with respect to the many types of DNA adducts they
induce. Carcinogens such as 2-acetylaminofluorene and
the polycyclic aromatic hydrocarbons form only a few
predominant adducts. For these types of carcinogens
the complex decision ofchoosing an appropriate dosim-
eter may be greatly simplified.
Choice of a molecular dosimeter should also take into
consideration the exposure regimen. Pulse dose and in
vitro experiments indicate DNA adducts that may be
mechanistically involved in the induction of cancer by
correlating their persistence with the carcinogenicity of
the chemical and bymeasuringthe extent to whichthey
interferewiththefidelityofDNAreplication. However,
these experiments may not accurately portray the ki-
netics of formation and repair that operate during
chronic exposure regimens such as those used in most
rodent bioassays or encountered during environmental
exposures.
In addition to DNA adduct formation related to
known chemical exposure, DNA damage can occurfrom
unknown exposures such as irradiation and contami-
nants in the diet, air, or water. Presently, such spon-
taneous DNA damage cannot be quantified, but it is
likely to play a role in spontaneous neoplasia, such as
occurs in unexposed control animals (15). Spontaneous
DNA damage may also be involved in carcinogenic re-
sponses of nongenotoxic carcinogens.
As mentioned above, different DNA adducts have
different efficiencies for causing mispairing and there-
fore different probabilities for inducing mutations. Un-
der ideal circumstances such data would be known for
each DNAadductpresentinatissue. Thus, thequantity
ofeachmoleculardosimeteranditsefficiencyforcausing
mutations could be utilized in quantitative risk assess-
ment. It is clear, however, that this alone will not be
adequate. Cell replication is an essential component of
every stage of the carcinogenic process. Mechanisti-
cally, replication ofDNA containingcarcinogen-induced
or spontaneously occurring adducts produces mutations
in the daughter strand (Fig. 1). When these mutations
occur at critical sites in the genome, they are part of
the irreversible and heritable changes involved in the
initiation process ofchemical carcinogenesis. Promotion
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FIGURE 2. Schematic of the role of cell proliferation in the initiation, promotion, and progression of carcinogenesis. The extent of clonal
expansion necessary for second or third mutational events is dependent on the amount ofspontaneous and chemically induced DNA damage.
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FIGURE 3. Accumulation of 04-EtdT during continuous exposure of rats to 0.4 (U), 1 (e), 4 (A), 10 (0), 40 (0), or 100 (A) ppm DEN. Adduct
concentrations are expressed versus time of exposure, 1, 4, 7, 14, 28, 49, or 70 days. Note the log scale of the y axis. Bars, mean ± SE
for three to four animals. The 04-EtdT concentrations were below the limit of detection of the radioimmunoassay (< 0.2 pmole 04-EtdT/
,umole dT) for exposure of 0.4 ppm DEN for 1, 4, and 7 days and 1 ppm DEN for 1 day. From Boucheron (20).
has been described as cell proliferation leading to the
selective clonal expansion oftheinitiated cellpopulation
(Fig. 2). This expansion increases the probability offur-
ther genetic alterations in the initiated cell population
believed to be necessary in the multistage process of
carcinogenesis (16,17). In the final stage ofcarcinogen-
esis, cell proliferation is essential for the irreversible
progression from benign focal proliferations to malig-
nant neoplasms (16).
Cell replication is frequently increased in tissues ex-
posed to toxic doses of a chemical. Thus, the extent of
cellproliferation can varygreatlybetween high and low
exposures. Since cell proliferation is clearly involved in
carcinogenesis, such dose-responsive changes need to
be factored into the dose response for carcinogenesis.
Thebestdataforextrapolatingthe extentofinitiation
from high to low exposures should be provided by the
combination of molecular dose, coupled with efficiency
for mispairing for each molecular dosimeter and the
extent of cell proliferation over the range of exposure
from that tested in animals to that expected forhumans
(Fig. 1). Cell proliferation also should modulate clonal
expansion and second mutational events in a dose-re-
sponsive manner. While we do not have a complete un-
derstanding ofthese interactions for a single chemical,
data covering one to three orders of magnitude of ex-
posure are becoming available for several carcinogens
on the molecular dosimetry ofmajor DNA adducts and
the extent ofcell proliferation. Examples ofthese data
are described in the following sections.
Diethyinitrosamine
Diethylnitrosamine (DEN) represents one of the
best-studied chemical carcinogens. Chronic bioassay
data, completewithdetailedanalysesoftumorincidence
and survival, are available covering exposures over
three orders of magnitude (18). Research on the for-
mation and repair of DNA adducts induced by DEN
have shown that 04-EtdT is the major promutagenic
adduct in liver DNA of chronically exposed rats (11).
Although 06-EtdG is chemically formed at concentra-
tions three- to fourfold greater than 04-EtdT, it is ef-
ficiently removed by the 06-alkylguanine-DNA alkyl-
transferase. In contrast, 04-EtdT is repaired slowly,
having a t½ ofapproximately 11 days (19). This leads to
concentrations of 04-EtdT that are approximately 50
times higher than 06-EtdG.
More recently, experiments on the molecular dosi-
metry of 04-EtdT have been conducted using rats ex-
posed to 0, 0.4, 1, 4, 10, 40, or 100 ppm DEN in the
drinking water for up to 70 days (20). As shown in
Figure 3, 04-EtdT accumulated in liver DNA in a dose-
and time-dependent manner. All exposure groups had
04-EtdT concentrations that reached apparent steady-
state. The time to steady-state appeared to be dose-
dependent. The two higher exposures attained nearly
90% of steady-state concentrations by 7 days; lower
exposures took somewhat longer. The apparent steady-
state concentrations of 04-EtdT were relatively linear
with respectto dose from0.4to40ppm. Concentrations
at the highest exposure (100 ppm) were lowerthan pre-
dicted by linear extrapolation.
Cell replication also increased in a dose- and time-
dependent manner at higher DEN concentrations (Fig.
4). However, thenumbers oflabeledhepatocytesinrats
exposed to 1 or 0.4 ppm DEN were not significantly
greaterthan those ofcontrols, indicatingthat increased
cell replication is primarily associated with exposure to
high doses ofDEN. Labeling indices were increased as
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FIGURE 4. The percent of hepatocytes labeled with r3H]thymidine
during exposure to O(X), 0.4(O), l(O), 4(A), 10(o), 40(o), or 100(A)
ppm DEN.
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FIGURE 5. Induction of GGT + foci in the right median hepatic lobe
during continuous administration of DEN.
much as 15 times that of controls in the left lobes of
rats exposed to 100 ppm DEN and averaged a threefold
increase in animals exposed to 10 or 4 ppm DEN.
The interaction of promutagenic DNA adducts, such
as 04-EtdT, and cell replication in carcinogenesis is sup-
ported by data on hepatocyte initiation using the same
DEN exposure conditions. Hepatocyte initiation
showed similar trends, with the number of growth-se-
lected y-glutamyltransferase positive (GGT+) foci in-
creasing with both dose and time. At 40 ppm, the high-
est DEN concentration studied, hepatocyte initiation
increased rapidly and then plateaued (12,21). At 10 and
4 ppm DEN, hepatocyte initiation appeared to be de-
pendent on the product of DEN concentration and time
of exposure and was unaffected by the rate of DEN
consumption (Fig. 5) (21). These data are consistent
with data on 04-EtdT and cell proliferation. At 40 ppm,
there was a marked increase in cell proliferation (ap-
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FIGURE 6. Concentration of 06-methylguanine in respiratory and
olfactory mucosa of DNA ofrats exposed to NNK. The data have
been normalized per unit dose of NNK and demonstrate that low
doses of NNK are more efficient than high doses in producing o6-
methylguanine in the respiratory portion of the nasal passages.
From Belinsky et al. (5).
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FIGURE 7. Concentration of covalently bound formaldehyde in res-
piratory mucosal DNA normalized per part per million of inhaled
formaldehyde. Formaldehyde isless efficientinproducingcovalent
binding at low versus high exposures. Data calculated from Ca-
sanova-Schmitz et al. (23).
proximately ninefold), whereas at 10 and 4 ppm there
was a three- to fourfold increase. Concentrations of 04-
EtdT were linear with the concentration of DEN in
drinking water at all three exposures. The plateau in
hepatocyte initiation is believed to represent a steady-
state of initiated hepatocytes, whereby the number of
newly initiated hepatocytes equals the number of pre-
viously initiated hepatocytes that are killed due to cy-
totoxicity. The average focus in animals exposed to 40
ppm also had agreatervolume after4weeks ofexposure
than did foci induced by exposure to 10 and 4 ppm,
suggesting additional selection pressure due to the in-
crease in cell proliferation. Unfortunately, this study
suggests that growth-selected GGT+ foci will not be
useful short-term indicators of initiation in investiga-
tions at lower DEN exposures, since an extrapolation
to the carcinogenic concentration of 1 ppm DEN pre-
dicts that it would take nearly 80 weeks to produce 100
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FIGURE 8. Compilation of all rat cell turnover data using the 18-hr [3H]thymidine pulse. Exposures were 0.5 (0), 2 (0), and 6 (A) ppm
formaldehyde 6 hr/day and the combined data from 12 ppm 3 hr/day and 15 ppm 6 hr/day (U). From Swenberg et al. (24).
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FIGURE 9. Dose-dependent similarity of P2 cell labeling index ob-
served in male rat kidney during 3 weeks of inhalation exposure
to unleaded gasoline and the number of renal epithelial tumors
found in male rats exposed to unleaded gasoline for 2 years. From
Short et al. (28).
GGT+ foci/cm3. Even this may be an overestimate as
cell proliferation was not increased at 1 ppm DEN.
NNK
Although the molecular dose of 04-EtdT was nearly
linear over DEN concentrations covering 2.5 orders of
magnitude, a different phenomena was evident for O6-
Formaldehyde
The opposite scenario exists for formaldehyde. Mo-
lecular dosimetry experiments by Heck and co-workers
have demonstrated a sublineardose-response for DNA-
protein cross-links (22,23). Formaldehyde exposures of
6 ppm or greater result in disproportionately more
DNA-protein cross-links per part per million formal-
dehyde than occur at concentrations of 4 ppm or less
(Fig. 7). This is the result of saturation ofglutathione-
dependent pathways for detoxification. Of great inter-
estisthefactthatamajornonlinearity informaldehyde-
inducednasal canceroccursbetween6and 15ppm, even
though DNA-protein cross-links are linearly related to
6162 SWENBERG ET AL.
external exposure over these concentrations. Again,
marked increases in cell proliferation at 15 ppm for-
maldehyde offer the best explanation (Fig. 8) (24).
Unleaded Gasoline
Chronic exposure tounleadedgasolineinduces kidney
tumors in male rats, but not female rats or either sex
ofmice. This carcinogenic response is believed to result
from the reversible binding of components of gasoline
or their metabolites to at2u-globulin, a low molecular
weight protein found in the kidney of male, but not
female rats (25-27). This binding is thought to alter the
protein's conformation, making it less digestible. The
resultant protein overload ofthe P2 segment epithelial
cells causes cell death and a sustained increase in cell
proliferation (26,28) that exhibits a dose-response sim-
ilar to that of renal tumor induction (Fig. 9). Previous
studies have demonstrated alackofgenotoxicity forthe
same sample of unleaded gasoline (29-31). Thus, it is
likely that the increase in renal cancer in male rats
represents promotion of spontaneously initiated renal
epithelial cells that is secondary to a sex- and species-
specific cytotoxicity. Preliminary data from a large ini-
tiation-promotion experiment support this interpreta-
tion.
Conclusions
Data on this divergent group ofchemical carcinogens
clearly demonstrate that several parameters represent
critical facets in understanding the scientific basis for
dose-response in carcinogenesis. Two critical determi-
nants in the dose response of carcinogenesis are cell
proliferation and the molecular dose of DNA adducts.
Cell proliferation data can be obtained for any exposure
regimen desired. As such, cell proliferation represents
an important type ofdata that can be factored into the
risk assessment process. Based on earlier studies of
Moolgavkar (32), preliminary models employing such
data are under development in several laboratories.
Likewise, efforts are underway to use data on DNA
adducts in place of external exposure (2). It is obvious
from the data presented that a generic approach that
assumes equal effects per unit dose between high and
low exposure is almost certain to be incorrect. Thus,
considerable effort and support must be given to this
emerging field, if quantitative risk assessment is to be
based on a firm scientific foundation.
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